FDA approves aceclidine eye drops for the treatment of presbyopia

Published on August 15, 2025
It is anticipated that Vizz, manufactured by Lenz Therapeutics, will become commercially available in the US by the end of 2025
Continue reading on website
Other news

Study demonstrates Lumenis's DMSt effectivity in addressing lower lid laxity, improving blinking quality

August 15, 2025
The study explored the use of DMSt, used in OptiLIFT, in enhancing eyelid muscle function, improving blink dynamics, and consequently alleviating dry eye symptoms.

Prevent Blindness implements Diabetes + the Eyes Advisory Committee to combat diabetes-related eye diseases

August 15, 2025
The committee will work to help the organization increase awareness and early identification of diabetes-related eye diseases, improve access to eye care treatment, policy development, research, and surveillance.